Annual CFF
$1.44 M
-$72.18 M-98.04%
31 March 2022
Summary:
Sio Gene Therapies annual cash flow from financing activities is currently $1.44 million, with the most recent change of -$72.18 million (-98.04%) on 31 March 2022. During the last 3 years, it has fallen by -$72.18 million (-98.04%).SIOX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
$0.000.00%
31 December 2022
Summary:
Sio Gene Therapies quarterly cash flow from financing activities is currently $0.00, unchanged on 31 December 2022.SIOX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$0.00
-$962.00 K-100.00%
31 December 2022
Summary:
Sio Gene Therapies TTM cash flow from financing activities is currently $0.00, with the most recent change of -$962.00 thousand (-100.00%) on 31 December 2022.SIOX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -98.0% | -100.0% | -100.0% |
| 5 y5 years | -98.3% | +100.0% | -100.0% |
SIOX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -99.6% | -100.0% | -100.0% |
Sio Gene Therapies Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2022 | - | $0.00(0.0%) | $962.00 K(0.0%) |
| June 2022 | - | $0.00(0.0%) | $962.00 K(-33.2%) |
| Mar 2022 | $1.44 M(-98.0%) | $0.00(-100.0%) | $1.44 M(-96.2%) |
| Dec 2021 | - | $962.00 K(>+9900.0%) | $38.20 M(-42.3%) |
| Sept 2021 | - | $0.00(-100.0%) | $66.23 M(-22.9%) |
| June 2021 | - | $479.00 K(-98.7%) | $85.85 M(+16.6%) |
| Mar 2021 | $73.62 M(+77.5%) | $36.76 M(+26.8%) | $73.62 M(-31.7%) |
| Dec 2020 | - | $28.99 M(+47.8%) | $107.72 M(+81.2%) |
| Sept 2020 | - | $19.62 M(-267.0%) | $59.45 M(+71.1%) |
| June 2020 | - | -$11.75 M(-116.6%) | $34.75 M(-16.2%) |
| Mar 2020 | $41.48 M(-52.4%) | $70.86 M(-467.5%) | $41.48 M(+843.4%) |
| Dec 2019 | - | -$19.28 M(+279.6%) | $4.40 M(-91.4%) |
| Sept 2019 | - | -$5.08 M(+1.3%) | $51.42 M(-37.3%) |
| June 2019 | - | -$5.01 M(-114.8%) | $82.05 M(-5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | $87.07 M(-36.2%) | $33.77 M(+21.7%) | $87.07 M(+62.4%) |
| Dec 2018 | - | $27.75 M(+8.6%) | $53.62 M(+106.7%) |
| Sept 2018 | - | $25.54 M(>+9900.0%) | $25.95 M(+2416.9%) |
| June 2018 | - | $10.00 K(-96.9%) | $1.03 M(-99.2%) |
| Mar 2018 | $136.40 M(+181.0%) | $324.00 K(+356.3%) | $136.40 M(-28.1%) |
| Dec 2017 | - | $71.00 K(-88.7%) | $189.60 M(+0.0%) |
| Sept 2017 | - | $626.00 K(-99.5%) | $189.53 M(+0.3%) |
| June 2017 | - | $135.38 M(+152.9%) | $188.91 M(+289.2%) |
| Mar 2017 | $48.54 M(-85.5%) | $53.53 M(>+9900.0%) | $48.54 M(-1072.7%) |
| Dec 2016 | - | $0.00(-100.0%) | -$4.99 M(-0.0%) |
| Sept 2016 | - | $10.00 K(-100.2%) | -$4.99 M(-11.9%) |
| June 2016 | - | -$5.00 M(<-9900.0%) | -$5.67 M(-101.7%) |
| Mar 2016 | $334.94 M | $0.00(-100.0%) | $334.94 M(0.0%) |
| Dec 2015 | - | -$1000.00(-99.8%) | $334.94 M(-0.0%) |
| Sept 2015 | - | -$666.00 K(-100.2%) | $334.94 M(-0.2%) |
| June 2015 | - | $335.61 M | $335.61 M |
FAQ
- What is Sio Gene Therapies annual cash flow from financing activities?
- What is the all time high annual CFF for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Sio Gene Therapies?
- What is Sio Gene Therapies TTM cash flow from financing activities?
- What is the all time high TTM CFF for Sio Gene Therapies?
What is Sio Gene Therapies annual cash flow from financing activities?
The current annual CFF of SIOX is $1.44 M
What is the all time high annual CFF for Sio Gene Therapies?
Sio Gene Therapies all-time high annual cash flow from financing activities is $334.94 M
What is Sio Gene Therapies quarterly cash flow from financing activities?
The current quarterly CFF of SIOX is $0.00
What is the all time high quarterly CFF for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly cash flow from financing activities is $335.61 M
What is Sio Gene Therapies TTM cash flow from financing activities?
The current TTM CFF of SIOX is $0.00
What is the all time high TTM CFF for Sio Gene Therapies?
Sio Gene Therapies all-time high TTM cash flow from financing activities is $335.61 M